A Novel Chronic Kidney Disease Phenotyping Algorithm Using Combined Electronic Health Record and Claims Data

References

• System USRD. 2021 USRDS annual data report: epidemiology of kidney disease in the United States; 2021. Available from: https://adr.usrds.org/2021. Accessed February 22, 2023.
   Google Scholar
• Chen TK, Knicely DH, Grams ME. Chronic kidney disease diagnosis and management: a review. JAMA. 2019;322(13):1294–1304. doi:10.1001/jama.2019.14745
   PubMed Web of Science ®Google Scholar
• Porter AC, Lash JP, Xie D, et al. Predictors and outcomes of health-related quality of life in adults with CKD. Clin J Am Soc Nephrol. 2016;11(7):1154–1162. doi:10.2215/cjn.09990915
   PubMed Web of Science ®Google Scholar
• Tonelli M, Wiebe N, Guthrie B, et al. Comorbidity as a driver of adverse outcomes in people with chronic kidney disease. Kidney Int. 2015;88(4):859–866. doi:10.1038/ki.2015.228
   PubMed Web of Science ®Google Scholar
• Desai R, Park H, Brown JD, Mohandas R, Pepine CJ, Smith SM. Comparative safety and effectiveness of aldosterone antagonists versus beta-blockers as fourth agents in patients with apparent resistant hypertension. Hypertension. 2022;79(10):2305–2315. doi:10.1161/hypertensionaha.122.19280
   PubMed Web of Science ®Google Scholar
• Chan YH, Lee HF, See LC, et al. Effectiveness and safety of four direct oral anticoagulants in Asian patients with nonvalvular atrial fibrillation. Chest. 2019;156(3):529–543. doi:10.1016/j.chest.2019.04.108
   PubMed Web of Science ®Google Scholar
• Paik JM, Patorno E, Zhuo M, et al. Accuracy of identifying diagnosis of moderate to severe chronic kidney disease in administrative claims data. Pharmacoepidemiol Drug Saf. 2022;31(4):467–475. doi:10.1002/pds.5398
   PubMed Web of Science ®Google Scholar
• Muntner P, Gutiérrez OM, Zhao H, et al. Validation study of medicare claims to identify older US adults with CKD using the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Am J Kidney Dis. 2015;65(2):249–258. doi:10.1053/j.ajkd.2014.07.012
   PubMed Web of Science ®Google Scholar
• Winkelmayer WC, Schneeweiss S, Mogun H, Patrick AR, Avorn J, Solomon DH. Identification of individuals with CKD from medicare claims data: a validation study. Am J Kidney Dis. 2005;46(2):225–232. doi:10.1053/j.ajkd.2005.04.029
   PubMed Web of Science ®Google Scholar
• Fleet JL, Dixon SN, Shariff SZ, et al. Detecting chronic kidney disease in population-based administrative databases using an algorithm of hospital encounter and physician claim codes. BMC Nephrol. 2013;14:81. doi:10.1186/1471-2369-14-81
   PubMed Web of Science ®Google Scholar
• Kern EF, Maney M, Miller DR, et al. Failure of ICD-9-CM codes to identify patients with comorbid chronic kidney disease in diabetes. Health Serv Res. 2006;41(2):564–580. doi:10.1111/j.1475-6773.2005.00482.x
   PubMed Web of Science ®Google Scholar
• Vlasschaert ME, Bejaimal SA, Hackam DG, et al. Validity of administrative database coding for kidney disease: a systematic review. Am J Kidney Dis. 2011;57(1):29–43. doi:10.1053/j.ajkd.2010.08.031
   PubMed Web of Science ®Google Scholar
• Lin KJ, Glynn RJ, Singer DE, Murphy SN, Lii J, Schneeweiss S. Out-of-system care and recording of patient characteristics critical for comparative effectiveness research. Epidemiology. 2018;29(3):356–363. doi:10.1097/ede.0000000000000794
   PubMed Web of Science ®Google Scholar
• Nalichowski R, Keogh D, Chueh HC, Murphy SN. Calculating the benefits of a research patient data repository. AMIA Annu Symp Proc. 2006;2006:1044.
   PubMedGoogle Scholar
• Lin KJ, Singer DE, Glynn RJ, et al. Prediction score for anticoagulation control quality among older adults. J Am Heart Assoc. 2017;6(10). doi:10.1161/jaha.117.006814
   Web of Science ®Google Scholar
• Patorno E, Najafzadeh M, Pawar A, et al. The EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study programme: design and exposure accrual for an evaluation of empagliflozin in routine clinical care. Endocrinol Diabetes Metab. 2020;3(1):e00103. doi:10.1002/edm2.103
   PubMedGoogle Scholar
• Patorno E, Pawar A, Franklin JM, et al. Empagliflozin and the risk of heart failure hospitalization in routine clinical care. Circulation. 2019;139(25):2822–2830. doi:10.1161/circulationaha.118.039177
   PubMed Web of Science ®Google Scholar
• Fralick M, Chen SK, Patorno E, Kim SC. Assessing the risk for gout with sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes: a population-based cohort study. Ann Intern Med. 2020;172(3):186–194. doi:10.7326/m19-2610
   PubMed Web of Science ®Google Scholar
• Fralick M, Schneeweiss S, Redelmeier DA, Razak F, Gomes T, Patorno E. Comparative effectiveness and safety of sodium-glucose cotransporter-2 inhibitors versus metformin in patients with type 2 diabetes: an observational study using data from routine care. Diabetes Obes Metab. 2021;23(10):2320–2328. doi:10.1111/dom.14474
   PubMed Web of Science ®Google Scholar
• Patorno E, Htoo PT, Glynn RJ, et al. Sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists and the risk for cardiovascular outcomes in routine care patients with diabetes across categories of cardiovascular disease. Ann Intern Med. 2021;174(11):1528–1541. doi:10.7326/m21-0893
   PubMed Web of Science ®Google Scholar
• Gagne JJ, Glynn RJ, Avorn J, Levin R, Schneeweiss S. A combined comorbidity score predicted mortality in elderly patients better than existing scores. J Clin Epidemiol. 2011;64(7):749–759. doi:10.1016/j.jclinepi.2010.10.004
   PubMed Web of Science ®Google Scholar
• Kim DH, Glynn RJ, Avorn J, et al. Validation of a claims-based frailty index against physical performance and adverse health outcomes in the health and retirement study. J Gerontol a Biol Sci Med Sci. 2019;74(8):1271–1276. doi:10.1093/gerona/gly197
   PubMed Web of Science ®Google Scholar
• Kim DH, Patorno E, Pawar A, Lee H, Schneeweiss S, Glynn RJ. Measuring frailty in administrative claims data: comparative performance of four claims-based frailty measures in the US medicare data. J Gerontol Biol Sci Med Sci. 2020;75(6):1120–1125. doi:10.1093/gerona/glz224
   PubMed Web of Science ®Google Scholar
• Kim DH, Schneeweiss S, Glynn RJ, Lipsitz LA, Rockwood K, Avorn J. Measuring frailty in medicare data: development and validation of a claims-based frailty index. J Gerontol Biol Sci Med Sci. 2018;73(7):980–987. doi:10.1093/gerona/glx229
   PubMed Web of Science ®Google Scholar
• Gautam N, Bessette L, Pawar A, Levin R, Kim DH. Updating international classification of diseases 9th revision to 10th revision of a claims-based frailty index. J Gerontol Biol Sci Med Sci. 2021;76(7):1316–1317. doi:10.1093/gerona/glaa150
   PubMed Web of Science ®Google Scholar
• Greiner M, Pfeiffer D, Smith RD. Principles and practical application of the receiver-operating characteristic analysis for diagnostic tests. Prev Vet Med. 2000;45(1–2):23–41. doi:10.1016/s0167-5877(00)00115-x
   PubMed Web of Science ®Google Scholar
• Corrigan-Curay J, Sacks L, Woodcock J. Real-world evidence and real-world data for evaluating drug safety and effectiveness. JAMA. 2018;320(9):867–868. doi:10.1001/jama.2018.10136
   PubMed Web of Science ®Google Scholar
• Schneeweiss S, Avorn J. A review of uses of health care utilization databases for epidemiologic research on therapeutics. J Clin Epidemiol. 2005;58(4):323–337. doi:10.1016/j.jclinepi.2004.10.012
   PubMed Web of Science ®Google Scholar
• Wetmore JB, Yan H, Herzog CA, Weinhandl E, Reyes JL, Roetker NS. CKD progression in medicare beneficiaries with nonvalvular atrial fibrillation treated with apixaban versus warfarin. Am J Kidney Dis. 2021;78(2):180–189. doi:10.1053/j.ajkd.2020.12.004
   PubMed Web of Science ®Google Scholar
• Zhao JZ, Weinhandl ED, Carlson AM, St Peter WL. Glucose-lowering medication use in CKD: analysis of US medicare beneficiaries between 2007 and 2016. Kidney Med. 2021;3(2):173–182.e1. doi:10.1016/j.xkme.2020.09.016
   PubMedGoogle Scholar
• Patel PA, Liang L, Khazanie P, et al. Antihyperglycemic medication use among medicare beneficiaries with heart failure, diabetes mellitus, and chronic kidney disease. Circ Heart Fail. 2016;9(7). doi:10.1161/circheartfailure.115.002638
   Web of Science ®Google Scholar
• Delanaye P, Cavalier E, Pottel H. Serum creatinine: not so simple! Nephron. 2017;136(4):302–308. doi:10.1159/000469669
   PubMed Web of Science ®Google Scholar